These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 580745)
1. Uridine enhances the chemotherapeutic action of the 4'-demethylepipodophyllotoxin-thenylidene-glucoside (VM 26)-cyclophosphamide combination on i.m. implanted Ehrlich carcinoma. Osswald H Arzneimittelforschung; 1978; 28(3):387-8. PubMed ID: 580745 [TBL] [Abstract][Full Text] [Related]
2. [Overadditive synergism of combinations of cyclophosphamide with thymidine, adenosine or uridine in transplantation tumors]. Osswald H Arzneimittelforschung; 1972 Jul; 22(7):1184-8. PubMed ID: 4678126 [No Abstract] [Full Text] [Related]
3. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability]. Frankfurt OS Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353 [TBL] [Abstract][Full Text] [Related]
4. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities. Gupta RS; Singh B J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229 [TBL] [Abstract][Full Text] [Related]
5. Potentiated chemotherapeutic activity of 3,6-diamino-10-methyl-acridinium by combination with glycine or DL-alpha-alanine on the Ehrlich carcinoma. Osswald H Arzneimittelforschung; 1975 Oct; 25(10):1608-9. PubMed ID: 1243048 [TBL] [Abstract][Full Text] [Related]
6. [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV]. Misset JL; Pouillart P; Amiel JL; Schwarzenberg L; Hayat M; de Vassal F; Musset M; Belpomme D; Jasmin C; Albahary C; Depierre R; Mathé G Nouv Presse Med; 1975 Dec; 4(44):3117-20. PubMed ID: 768904 [TBL] [Abstract][Full Text] [Related]
7. [Effect of the combined use of pyrogenal and cyclophosphane on experimental tumors]. Kolosov AI; Krupkin RG Vopr Onkol; 1977; 23(10):90-2. PubMed ID: 595532 [TBL] [Abstract][Full Text] [Related]
8. Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside). Roberts D; Peck C; Hilliard S; Karas JG Cancer Res; 1981 Oct; 41(10):3891-5. PubMed ID: 7284998 [No Abstract] [Full Text] [Related]
9. 4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations. Rivera G; Avery T; Pratt C Cancer Chemother Rep; 1975; 59(4):743-9. PubMed ID: 1100225 [TBL] [Abstract][Full Text] [Related]
10. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts. Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with anticancer agents and OK-432. Kimura I; Onoshi T; Takano J; Osawa H; Yasuhara S Acta Med Okayama; 1974 Dec; 28(6):411-21. PubMed ID: 4142360 [No Abstract] [Full Text] [Related]
13. Serum protein reduction of the enhancement of methotrexate accumulation by vincristine and 4'-demethylepipodophyllotoxin in the Ehrlich ascites tumor cell in vitro. Gewirtz DA Cancer Res; 1985 Dec; 45(12 Pt 1):6290-2. PubMed ID: 4063980 [TBL] [Abstract][Full Text] [Related]
14. Suramin enhancement of the chemotherapeutic actions of cyclophosphamide or adriamycin of intramuscularly-implanted Ehrlich carcinoma. Osswald H; Youssef M Cancer Lett; 1979 May; 6(6):337-43. PubMed ID: 455271 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts. White JC; Hines LH; Rathmell JP Cancer Res; 1985 Jul; 45(7):3070-5. PubMed ID: 4005845 [TBL] [Abstract][Full Text] [Related]
16. Acute, chronic and terminal toxicity to 4'-demethylepipodophyllotoxin thenylidene glucoside (VM26) in mice. Hacker M; Roberts DW Cancer Res; 1975 Jul; 35(7):1756-60. PubMed ID: 1131830 [TBL] [Abstract][Full Text] [Related]
17. Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro. Yalowich JC; Fry DW; Goldman ID Cancer Res; 1982 Sep; 42(9):3648-53. PubMed ID: 6179605 [No Abstract] [Full Text] [Related]
18. VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors. Mechl Z; Rovný F; Sopková B Neoplasma; 1977; 24(4):411-4. PubMed ID: 904743 [TBL] [Abstract][Full Text] [Related]
19. [Changes in the state of plasma membrane proteins of tumor cells exposed to a polyene antibiotic and cyclophosphamide]. Oksman AIa; Shneĭder MA; Eremeeva AA; Karel'skaia NP; Tereshin IM Antibiotiki; 1981 Sep; 26(9):692-4. PubMed ID: 7294761 [TBL] [Abstract][Full Text] [Related]
20. Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy. Kimura I; Onoshi T; Yasuhara S; Watanabe T; Sugiyama M; Hiraki K Acta Med Okayama; 1974 Dec; 28(6):423-31. PubMed ID: 4142361 [No Abstract] [Full Text] [Related] [Next] [New Search]